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Low survival rate and muscle fiber-
dependent aging effects in the 
McArdle disease mouse model
Alberto Real-Martinez1, Astrid Brull2, Jordi Huerta1, Guillermo tarrasó1, Alejandro Lucia3,4,5, 
Miguel Angel Martin  4,5, Joaquin Arenas4,5, Antoni L. Andreu1,5, Gisela Nogales-Gadea5,6, 
John Vissing7, Thomas O. Krag  7, Noemi de Luna8,5 & tomàs pinós1,5
McArdle disease is an autosomal recessive disorder caused by the absence of the muscle glycogen 
phosphorylase, which leads to impairment of glycogen breakdown. The McArdle mouse, a model 
heavily affected by glycogen accumulation and exercise intolerance, was used to characterize disease 
progression at three different ages. The molecular and histopathological consequences of the disease 
were analyzed in five different hind-limb muscles (soleus, extensor digitorum longus, tibialis anterior, 
gastrocnemius and quadriceps) of young (8-week-old), adult (35-week-old) and old (70-week-old) mice. 
We found that McArdle mice have a high perinatal and post-weaning mortality. We also observed a 
progressive muscle degeneration, fibrosis and inflammation process that was not associated with an 
increase in muscle glycogen content during aging. Additionally, this progressive degeneration varied 
among muscle and fiber types. Finally, the lack of glycogen content increase was associated with the 
inactivation of glycogen synthase and not with compensatory expression of the Pygl and/or Pygb genes 
in mature muscle.
McArdle disease (glycogen storage disease V; myophosphorylase deficiency; OMIM database number ♯232600; 
ORPHA: 368) is an autosomal recessive disorder caused by pathogenic mutations in the gene (PYGM) encod-
ing the muscle isoform of glycogen phosphorylase (GP-M, also known as myophosphorylase)1,2. GP-M initiates 
the breakdown of muscle glycogen, leading to the release of glucose-1-phosphate in muscle fibers. Patients are 
unable to obtain energy from their muscle glycogen stores3, and present with exercise intolerance, usually in 
the form of reversible, acute crises of early exertional fatigue and contractures that can also be accompanied by 
rhabdomyolysis, as reflected by marked increases in serum levels of creatine kinase (CK) or even myoglobinuria 
(‘dark urine’)4,5. Naturally occurring or laboratory-generated animal disease models allow performing mechanis-
tic studies that provide insights into the pathophysiology of a disorder. In this context, a knock-in McArdle mouse 
model with the most common PYGM pathogenic mutation (p.R50X) mutation was developed by our group6. The 
McArdle mouse mimics the phenotype found in patients, characterized by hyperCKemia, myoglobinuria, and 
poor exercise performance6. Glycogen levels in muscle of the mouse McArdle model are elevated several fold 
more than found in people with McArdle disease6. Several studies have been performed in the McArdle mouse 
model, analyzing the disease phenotype in young (8-week-old)6–9 or adult mice (20-week-old)10–12. In these stud-
ies, it was observed that muscle contractions were affected by structural degeneration due to glycogen accumu-
lation and that glycolytic muscles fatigued prematurely10. Additionally, histological differences among glycolytic 
1Mitochondrial and neuromuscular Disorders Unit, Vall d’Hebron institut de Recerca, Universitat Autònoma de 
Barcelona, Barcelona, Spain. 2Sorbonne Université, INSERM UMRS_974, Center of Research in Myology, 75013, 
Paris, france. 3Faculty of Sport Sciences, Universidad Europea de Madrid, Madrid, Spain. 4Mitochondrial and 
Neuromuscular Diseases Laboratory, 12 de Octubre Hospital Research Institute (i+ 12), Madrid, Spain. 5centro de 
investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain. 6Grup de Recerca en Malalties 
Neuromusculars i Neuropediàtriques, Department of Neurosciences, Institut d’Investigacio en Ciencies de la Salut 
Germans trias i Pujol i campus can Ruti, Universitat Autònoma de Barcelona, Badalona, Spain. 7copenhagen 
Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, 
Denmark. 8Laboratori de Malalties neuromusculars, institut de Recerca Hospital de la Santa creu i Sant Pau, 
Universitat Autònoma de Barcelona, Barcelona, Spain. Alberto Real-Martinez and Astrid Brull contributed equally. 
Noemi de Luna and Tomàs Pinós jointly supervised. Correspondence and requests for materials should be addressed 
to T.P. (email: tomas.pinos@vhir.org)
Received: 1 October 2018
Accepted: 25 January 2019
Published: xx xx xxxx
opeN
2Scientific RepoRts |          (2019) 9:5116  | https://doi.org/10.1038/s41598-019-41414-8
www.nature.com/scientificreportswww.nature.com/scientificreports/
muscles were shown, as tibialis anterior (TA) muscles were invariably more damaged than quadriceps muscles, 
likely as a result of higher levels of glycogen metabolism in TA compared to quadriceps10. With respect to meta-
bolic adaptive responses, quadriceps from McArdle mice presented significant changes in protein levels involved 
in glucose metabolism, while distal muscles such as TA, extensor digitorum longus (EDL) and soleus showed 
barely any change11. Additionally, differential structural damage was also observed among fiber types; while type 
I/IIa, IIa, IIa/IIx and IIx fibers from hind limb muscles presented evident signs of degeneration, type I fibers 
remained largely unaffected10. As disease phenotype progression and its molecular consequences during the aging 
process remain largely unknown, in the present study we wanted to perform a longitudinal characterization of the 
McArdle mouse model to determine if the massive glycogen accumulation in myofibers (i) increased with aging 
and (ii) caused progressive and differential increase in muscle and fiber type degeneration. Therefore, we analyzed 
and characterized the molecular and histopathological consequences of aging in five different hind-limb muscles 
[soleus (oxidative), and EDL, TA, gastrocnemius and quadriceps (glycolytic muscles)] from three cohorts of mice 
aged 8, 35 and 70 weeks. Furthermore, as we have previously observed an unusually high mortality of McArdle 
mice10, we also wanted to analyze the survival rate of these mice throughout their life-span.
Material and Methods
Ethical approval. All experimental procedures were approved by the Vall d’Hebron Institutional Review 
Board (protocol number 13/04 CEEA; 35/04/08) and were conducted in accordance with the European 
Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (ETS 
1 2 3) and Spanish laws (32/2007 and R.D. 1201/2005).
Mice. Previously developed p.R50X/p.R50X knock-in McArdle mice, back-crossed for 10 generations to 
C57/6 J background, were used in this study6,7. To test for disease progression, three cohorts of mice aged 8, 35 
and 70 weeks were used. All cohorts had N = 12 both for wild-type (WT) and McArdle (McA) mice, with the 
exception of 70-week-old McA mice where the number of studied mice were 6. All mice were killed by cervical 
dislocation immediately before dissection of the hindlimb muscles soleus, gastrocnemius, EDL, TA and quadriceps.
Genotyping. Genotyping was performed for all post-weaning mice of the colony born between 01/01/2013 
and 05/08/2018 (n = 2,088) and 38 embryos (E 14.5) according to a protocol previously described6.
survival curve. The survival curve was calculated for all the genotyped post-weaning mice of the colony that 
were born between 01/01/2013 and 05/08/2018 (n = 2,088). The Kaplan-Meier survival function, also known 
as the product-Limit estimator was used13. For each mouse, the following data were entered (GraphPad Prism 
version 6.00 for Windows, GraphPad Software, La Jolla, CA, www.graphpad.com): 1) X-values: time (number of 
days alive until an event or censoring occurred); 2) Y-values: Y value is “1” when the mouse died at the specified 
time, and “0” when the mouse’s data was censored at that time.
Histology and immunohistochemistry. Dissected muscles were flash frozen in isopentane cooled in 
liquid nitrogen and stored at −80 °C until analysis. Twelve μm cryosections were stained with hematoxylin and 
eosin (H&E) for general histopathological evaluation as previously described6. Glycogen content was analyzed 
with periodic acid–Schiff (PAS) staining by sequentially incubating the sections with: periodic acid (Fisher 
Scientific; Hampton, NH) (0.5%) for 5 min, water wash, Schiff ’s solution (Merck-Millipore, Burlington, MA) 
for 15 min, water for 1 min, alcohol-xylol dehydration and DPX mounting (Sigma-Aldrich, St. Louis, MO)6. For 
immunohistochemistry, sections were fixed in 10% buffered formalin (Sigma-Aldrich) and subsequently blocked 
in buffer (3% fetal calf serum in PBS) prior to staining. For damage, regeneration, inflammatory, fibrosis, and 
fiber type overview and analysis, sections were stained with their corresponding antibodies (see Supplementary 
Table). Finally, sections were stained with 4′,6-diamidino-2-phenylin- dole (DAPI) nucleic acid stain reactive 
(Invitrogen; Carlsbad, CA), for 5 min and mounted with ProLongTM Gold Antifade reagent (Molecular probes; 
Eugene, OR). Images were taken using a FSX100 fluorescence microscope and the software FSX-BSW (Olympus; 
Tokyo, Japan).
Central nuclei quantification. For the assessment of centrally nucleated fibers (CNF), sections were 
stained for laminin (for antibodies, see Supplementary Table) to distinguish individual muscle fibers and DAPI to 
visualize the nuclei. Total and CNF were counted manually, and the results were recorded using the cell counter 
plug-in from the image J software 1.37 version (NIH; Roth Bethesda, MO). Between 491 and 5,079 fibers (median 
1682 fibers) from at least three different mice were counted per age and genotype. Results were expressed as 
the mean percentage of CNF per muscle. For enhanced visualization of nuclei staining surrounding the sarco-
plasmic membrane [(peripheral nuclei (PN)], laminin-DAPI staining images were opened in TIFF format with 
the Adobe Photoshop program (Adobe® Photoshop® CS5 extended v.12.0, San Jose, CA, USA) and tone- and 
saturation-adjusted.
Fiber size determination. Fiber size was calculated from laminin-DAPI stains using the minimal Feret’s 
diameter (Image J software ver. 1.37) to attain the fiber size least influenced by sample sectioning angle14. Between 
240 and 1,444 fibers (median 459 fibers) from at least three different mice were counted per age and genotype.
Fiber type staining and quantification. To identify individual and mixed fiber types, immunostains were 
made as triple stains for myosin heavy chain (MHC)I/MHCIIA/DAPI, MHCIIA/MHCIIX/DAPI, and MHCIIX/
MHCIIB/DAPI (for antibodies, see Supplementary Table). The different fiber types were counted manually. 
Between 50 and 980 fibers (median 505 fibers) from at least three different mice were counted per age, genotype 
and fiber type. The results were recorded using the cell counter plug-in as described above and expressed as the 
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percentage of (i) fiber types per muscle, and (ii) CNF per fiber type. For metabolic analyses, type I, IIa and I/
IIa were grouped as oxidative fibers, while type IIx, IIa/IIx and IIx/IIb as glycolytic fibers15. The results were 
expressed as the percentage of each group relative to total number of fibers counted.
mRNA analysis. Total RNA was obtained from gastrocnemius muscle as previously described16 follow-
ing the manufacturer instructions of TRIzol (Invitrogen). RNA was treated with DNase I, amplification grade 
(Invitrogen) to eliminate any traces of DNA. Complementary DNA was synthesized from RNA using the 
high-capacity complementary DNA archive kit (Applied Biosystems, Foster City, CA), which uses random 
primers. We used real-time PCR, with TaqMan fluorogenic probes in a 7900 Real-Time PCR System (Applied 
Biosystems) to assess gastrocnemius RNA levels of: (i) Pygm gene (Mm00478582_m1); (ii) glycogen phosphoryl-
ase, brain isoform (Pygb) gene (Mm00464080_m1); and (iii) glycogen phosphorylase, liver isoform (Pygl) gene 
(Mm00500078_m1). Results were normalized to peptidylprolyl isomerase A (cyclophilin A, Ppia) gene messen-
ger RNA levels (probe Mm02342430_g1).
Western blot analysis. Muscle samples from gastrocnemius and TA were homogenized using Pellet pestles 
Cordless motor (Sigma-Aldrich) in cold homogenization buffer (Tris-Hcl 20 mM, NaCl 150 mM and Triton X100 
1%) and centrifuged at 10,000 g for 10 min at 4 °C. Proteins (30 μg) were resolved on CriterionTM TGXTM 4–15% 
Precast Midi gels (Biorad; Hercules, CA) at 150 V for 90 min and blotted to a polyvinylidene difluoride membrane 
(Immun-Blot® PVDF membrane, Biorad) using the Trans-Blot® SD Semi-dry Transfer Cell (Biorad) at 20 V for 
50 min. Membranes were incubated in primary antibodies overnight at 4 °C and in secondary antibodies for 
3 hours at room temperature (Supplementary Table). Ponceau S staining (Sigma-Aldrich) was used as a loading 
control for all the membranes. Membranes were developed with Immobilon Western Chemiluminiscent HRP 
Substrate (Merck-Millipore) and images obtained with a Fujifilm LAS 3000 imager (R&D Systems; Minneapolis, 
MN) and quantified with Image J, version 1.37.
Breedings (2013–2018)
WT x HTZ HTZ x HTZ McA x HTZ McA x McA
Statistics Total
WT (M) x 
HTZ (F)
HTZ (M) x 
WT (F)
HTZ (M) x 
HTZ (F)
McA (M) x 
HTZ (F)
HTZ (M) x 
McA (F)
McA (M) x 
McA (F)
Total number 
of breedings 9 10 47 58 6 9 N.A 139
Total number 
of litters 17 41 273 179 43 30 N.A 583
Total number 
of mice 103 189 1149 617 130 39 N.A 2227
Total number 
of males 45 102 578 325 64 19 N.A 1133
% of males 43,7 54,0 50,3 52,7 49,2 48,7 N.A 50,9
Total number 
of females 58 87 571 292 66 20 N.A 1094
% of females 56,3 46,0 49,7 47,3 50,8 51,3 N.A 49,1
Mice/litter
6,06 (±3,75) 4,61 (±3,69) 4,21 (±3,33) 3,45 (±2,75) 3,02 (±2,15) 1,30 (±1,74)
p < 0.0001 3,77 (±1,61)
5,03 (±3,73) 4,21 (±3,33) 3,36 (±2,64) 1,30 (±1,74)
Nº litters with 
100% mortality 3 13 61 48 7 14 N.A 146
% litters with 
100% mortality 5,5 22,3 24,8 35,9 N.A 22,1
Table 1. McArdle mice colony breeding results between 2013 and 2018. Abbreviations. (M): Males; (F): 
Females; N.A: Not applicable. To calculate the statistical significance of the number of mice per litter the One-
Way ANOVA with post-hoc Tukey Honestly Significant Difference (HSD) test was applied.
Breedings
Post-weaning genotyping Embryo genotyping
WT x HTZ HTZ x HTZ HTZ x McA HTZ x HTZ
Offsprings WT HTZ McA WT HTZ McA WT HTZ McA WT HTZ McA
Nº mice per genotype 96 137 N.A 368 718 67 N.A 580 122 12 17 9
Genotype % 41.2 58.8 N.A 31.9 62.3 5.8 N.A 82.6 17.4 31.5 44.7 23.6
Expected Genotype % 50 50 N.A 25 50 25 N.A 50 50 25 50 25
Statistics Fisher’s test p = 0.035
Chi-square test 
p < 0.001
Fisher’s test 
p < 0.001
Chi-square test 
p = 0.864
Table 2. McArdle mice colony genotyping results between 2013 and 2018. Abbreviations. N.A: Not applicable. 
To compare obtained versus expected mouse genotypes Fisher’s exact test (two-group comparisons, i.e., WT x 
HTZ and HTZ x McA breedings) and Chi-square test (three-group comparisons, i.e., HTZ x HTZ breedings) 
were used.
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Muscle glycogen. One hundred and fifty mg of tissue were boiled for 30 min with 30% KOH and, subse-
quently, 1.2 volumes of 95% ethanol were added to precipitate glycogen. After a centrifugation step (25 min at 
840 g), the glycogen pellet was resuspended in 0.3 ml of water. Next, 0.1 ml of 5% phenol was added to 0.1 ml of 
sample and treated with 0.5 ml of H2SO4 (to hydrolyze glycogen to glucose). The mixture was allowed to stand for 
30 min at room temperature and the glucose released was measured spectrophotometrically at 490 nm. A stand-
ard curve made with glycogen purified from rabbit liver (Sigma-Aldrich), ranging from 0.1 to 0.8 mg mL−1, was 
processed in parallel. The results were expressed as mg glycogen (g wet tissue)−1,17.
statistics. All statistical analyses were performed using the GraphPad Prism software. To analyze the aging 
effects on muscle fiber size determination (mFd), as well as the number of mice per litter in the colony breeding 
(normally distributed values), One-Way ANOVA with post-hoc Tukey Honestly Significant Difference (HSD) 
test was applied. To analyze the aging effects when values were not normally distributed (% CNF, % MHCe+, % 
fiber types, PN per fiber, glycogen content, mRNA and protein relative levels), the non-parametric Kruskal-Wallis 
One-Way ANOVA with multiple comparisons test (Dunn’s test) was used. To analyze the genotype effects in 
normally distributed values, a Student t-test was applied, whereas the non-parametric Mann-Whitney U-test 
was used when values were not normally distributed. To evaluate the distinct survival rates of each genotype 
(Kaplan- Meier curve), the log-rank (Mantel-Cox) test was used. To compare obtained versus expected mouse 
genotypes we used the Fisher’s exact test (two-group comparisons, i.e., WT x HTZ and HTZ x McA breedings) or 
the Chi-square test (three-group comparisons, i.e., HTZ x HTZ breedings).
Results
Perinatal mortality. During the period from January 2013 to May 2018 a total of 139 matings of the 
McArdle mouse model colony were performed. From these, 19 were wild-type (WT) x heterozygous (HTZ), 47 
HTZ x HTZ, 64 McArdle (McA) x HTZ and 9 McA x McA matings, resulting in a total of 583 litters and 2,227 
mice [1,133 males (51%) and 1,094 females (49%)] (Table 1). The number of offspring was significantly different 
among the distinct matings, showing that a higher presence of the mutant p.R50X allele in parents significantly 
reduced the number of mice per litter in the offspring (Table 1); additionally, the presence of the p.R50X allele in 
parents was also associated with an increased percentage of litters with a 100% mortality (Table 1). Furthermore, 
when the offspring mice originating from HTZ x HTZ and McA x HTZ matings were genotyped we observed 
a clear decrease in the proportion of McA offspring compared to the expected 25% and 50%, respectively, from 
Mendelian inheritance (Table 2). Genotyping of 38 embryos originating from HTZ x HTZ mating demonstrated 
a normal Mendelian distribution of McA mouse embryos (Table 2). These results suggest that McA mice have 
high perinatal mortality.
Post-weaning mortality. A survival curve for all post-weaning genotyped mice (n = 2,088; WT = 464; 
HTZ = 1,435; McA = 189; including males and females) was calculated. There was a significant reduction in the 
survival rate of McA mice compared with WT and HTZ (Fig. 1); the accumulative survival for WT was 99.3% 
in a serial time of 831 days, 98.9% for HTZ in a serial time of 1012 days, and only 44.7% in McA mice in a serial 
time of 997 days (Fig. 1).
Figure 1. Kaplan and Meier survival plot for the wild-type (WT), heterozygous (HTZ) and McArdle (McA) 
mice born between 01/01/2013 and 05/08/2018. There was a significant reduction in the survival rate of McA 
with respect HTZ and WT [p < 0.0001; log-rank (Mantel-Cox test)]. From 464 WT, 461 were censored and 3 
spontaneous deaths (events) occurred in 831 days; from 1435 HTZ, 1420 were censored and 15 events occurred 
in 1012 days; finally, from 189 McA, 137 were censored and 52 events occurred in 997 days.
5Scientific RepoRts |          (2019) 9:5116  | https://doi.org/10.1038/s41598-019-41414-8
www.nature.com/scientificreportswww.nature.com/scientificreports/
Figure 2. Histological characterization of McArdle mice. (A) H&E staining of the soleus, gastrocnemius, 
extensor digitorum longus (EDL), tibialis anterior (TA) and quadriceps muscles from 8-week-old wild-type 
(WT) and heterozygous (HTZ) and 8, 35 and 70-week-old McArdle (McA) mice. All scale bars correspond to 
75 µm. (B) Laminin-DAPI, Col IV-DAPI and FBN-DAPI stains of TA muscles from 8, 35 and 70-week-old McA 
and 70-week-old WT. All scale bars correspond to 150 µm. (C) Tone modified (Adobe® Photoshop® tone and 
saturation adjustments were set at −105 and +25, respectively) laminin-DAPI stain of soleus and TA muscles 
from 70-week-old WT and 8, 35 and 70-week-old McA. Due to the tone modification laminin staining has 
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Degeneration, fibrosis and inflammation. Histopathological evaluation of soleus, EDL, gastrocnemius, 
TA and quadriceps from 8, 35 and 70-week-old McA mice using H&E-staining revealed several muscle fibers in 
disarray, variations in fiber size, with large intra-fiber voids and some CNF and an increase in the extracellular 
matrix area, that became more apparent in 70-week-old mice (Fig. 2A). Additionally, detailed images from 8, 
35 and 70-week-old McA EDL muscle showed the presence of muscle regions with a high proportion of CNF 
along with an increase in the number of central nuclei per fiber in the EDL of 70-week-old mice (Supplementary 
Fig. 1). To assess whether this age-related increase in the extracellular matrix area was associated with fibrosis, 
muscle sections were stained with laminin, collagen IV (Col IV) and fibronectin (FBN) antibodies. TA from 
8, 35 and 70-week-old McA mice clearly demonstrated fibrosis compared to age-matched WT mice (Fig. 2B 
and Supplementary Fig. 2A). Furthermore, in order to determine whether this finding was also present in other 
muscle types, laminin-fibronectin double stain as well as collagen I (Col I) and Col IV single stains were per-
formed in EDL, quadriceps and soleus from WT and McA mice; in these muscles, the laminin and fibronectin 
stains were specially marked in the EDL and soleus of 70-week-old McA, while in quadriceps the increase was 
less evident (Supplementary Fig. 2B). Additionally, using laminin-DAPI stain, we observed an increase in the 
number of nuclei staining surrounding the sarcoplasmic membrane of TA and soleus muscle fibers, which was 
already apparent in 8-week-old McA mice, with a subtle increase in 35 and 70-week-old McA mice (Fig. 2C and 
Supplementary Fig. 3). To determine whether this increase was associated with an increment in the presence of 
inflammatory cells, we stained TA and quadriceps muscles with the CD68 macrophage marker18, and observed 
that high intensities of CD68 staining co-localized with the presence of multiple nuclei outside the sarcoplasmic 
membrane (Fig. 2D), reflecting the presence of an inflammatory response. Additionally, CD68, Col IV and DAPI 
stains co-localized in the quadriceps of 70-week-old McA mice, suggesting that fibrosis and inflammation are 
associated processes in the skeletal muscle of these mice (Fig. 2D).
Age-dependent increase in fiber degeneration. Muscle fiber types IIa and IIx have previously been 
found to be the most degenerated muscle fibers in 20-week-old McA mice due to massive intermyofibrillar and 
subsarcolemmal glycogen accumulation disturbing the ultrastructure10. In the present study, IIa and IIx fibers 
degeneration was observed in soleus muscle of 8-week-old McA mice, which was further exacerbated in 35- and 
70-week-old McA animals (Fig. 3A,C); interestingly, type I fibers presented almost normal morphology in the 
three age groups (Fig. 3A,C). Similarly, degeneration of IIa, IIx and IIa/IIx fibers was already observed in TA mus-
cle from 8-week-old McA mice, although it was more pronounced in 70-week-old mice (Fig. 3B). Additionally, 
as previously reported10, mixed IIx/IIb fibers were less affected than IIx fibers alone (Fig. 3D). Of note, higher 
accumulations of the extracellular matrix protein fibronectin were observed in TA regions where IIx fibers were 
predominant, while in areas with IIx/IIb fibers, less fibronectin staining was seen (Fig. 3D); thus, an inverse cor-
relation between fibrosis and presence of IIx/IIb fibers might exist.
Muscle regenerates differentially depending on fiber type composition. In order to assess 
whether McA mice muscles were progressively affected by the excess of glycogen, we quantified the presence of 
CNF as a marker for the ongoing degeneration/regeneration cycles known to exist in McA mouse muscles10. The 
percentage of CNF was superior in McA vs. WT in the soleus, gastrocnemius, EDL and TA in the three age groups 
(Fig. 4A); additionally, there was an age-dependent increase in the mean percentage of CNF in the soleus of the 
McA mice (8-, 35- and 70-week-old: 11, 24 and 28%, respectively) that was not observed in gastrocnemius, EDL, 
TA and quadriceps (Fig. 4A). Thus, while TA showed the highest proportion of CNF in 8-week-old McA mice 
(24%), the soleus muscle presented the highest percentage in 70-week-old McA animals (28%) (Fig. 4B).
Increased number of CNF in type I and IIx/IIb fibers during aging. To assess if specific fiber types 
were more prone to degeneration, the percentage of CNF was quantified within the different fiber types in one 
oxidative muscle (soleus) and two glycolytic muscles (EDL and TA). In soleus muscle, CNFs were increased in 
type I fibers between 8 and 70-week-old McA mice, whereas no increase was observed in IIa fibers (Fig. 5A). In 
the EDL muscle, there was a significant increase in the percentage of CNF in type IIx/IIb fibers between 70 and 
8-week-old McA mice (Fig. 5B), In TA, no change in CNF was found between the different ages (Fig. 5C).
Co-localization of MHCe with IIa, IIa/IIx and IIx fibers. We next analyzed the expression of the embry-
onic myosin heavy chain (MHCe), a marker of ongoing (acute) regeneration in McA mice through aging and 
different muscles/fiber types. In this regard, McA mouse muscle sections were double stained for Col IV and 
MHCe and for type I/IIa/IIx fibers. Both in soleus from 8 and 35-week-old McA mice and TA from 70-week-old 
McA mice, MHCe was only found in types IIa, IIa/IIx and IIx, but not in type I fibers. (Fig. 6A–C). Additionally, 
we also observed that there was a general trend towards a decrease in the number of MHCe positive fibers during 
aging in all the three muscles analyzed (Fig. 6D).
Fiber size and fiber type composition. To determine whether muscle degeneration affected muscle fiber 
size in McA mice, mFd was measured in the different muscles and age groups; while there were ~18% and ~4% 
mean fiber size increases in soleus and quadriceps, respectively (Fig. 7A), between 70 and 8-week-old McA mice, 
~4, ~6 and ~19% mean fiber size decreases were observed in TA, gastrocnemius and EDL, respectively, between 
the same ages (Fig. 7B). These results suggest that among the analyzed muscles, soleus and quadriceps fibers 
become dark blue, whereas DAPI staining has become light blue/green and nuclei are much more highlighted. 
All scale bars correspond to 150 µm. (D) CD68 (pan-macrophage marker)-DAPI staining of TA from 70-week-
old McA and CD68, Col IV and DAPI stains of quadriceps from 70-week-old McA mice.
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are the least affected by McA disease during aging process in terms of fiber size. To further confirm the specific 
degeneration of IIa and IIx fibers during aging, we measured the mFd for each specific fiber type in the soleus of 
McA mice and observed that type I fibers were significantly larger than IIa and IIx fibers in 8-week-old McA ani-
mals (Fig. 7C). Additionally, while there was an ~8% increase in type I fiber size between 8 and 70-week-old McA 
mice, 7.5 and 11% decreases in type IIa and IIx fiber size, respectively, were observed between the same ages in 
the soleus of McA mice (Fig. 7D). These results suggest that repeated episodes of muscle damage and subsequent 
regeneration over mice life do not affect type I fiber size, but clearly reduce that of type IIa and IIx fibers. In soleus, 
EDL TA muscle we did not detect any changes in fiber type composition between the different ages and genotypes 
(Supplementary Fig. 4A–C). Next, we wanted to determine whether the overall muscle metabolism was affected. 
Fiber types were grouped either as oxidative (I, IIa and I/IIa) or glycolytic (IIx, IIa/IIx and IIx/IIb). While no 
significant changes were observed in both TA and EDL glycolytic muscles (Supplementary Fig. 5B,C), the soleus 
of McA mice demonstrated a progressive increase in the number of glycolytic fibers and a decrease in oxidative 
fibers with age, opposite of what was found in soleus of WT mice. (Supplementary Fig. 5A).
Figure 3. Age-dependent increase of IIa and IIx fibers atrophy. (A) Fiber type stains for myosin heavy chain 
(MHC) I, IIa, IIx, and IIb as overlapping double stains in soleus muscle from McArdle (McA) mice demonstrate 
that type I fibers are not affected structurally by glycogen accumulation in any of the ages analyzed, whereas 
type IIa, IIa/IIx mixed, and IIx fibers present an age-dependent increase in atrophy. All scale bars correspond to 
150 µm. (B) MHC double stain in tibialis anterior (TA) muscle shows atrophy in IIa, IIx and mixed IIa/IIx fibers 
in 8-week-old McArdle (McA) mice, which is further exacerbated in 70-week-old McA mice. Mixed IIx/IIb 
fibers seems to be protected from atrophy. Longitudinal sections are also shown. (C) Consecutive soleus sections 
from 35-week-old McA mice stained for I/IIa and II/IIx fibers showing almost intact type I fibers but highly 
degenerated IIa, IIx and IIa/IIx fibers. Scale bars correspond to 150 µm. All scale bars correspond to 150 µm, 
while in longitudinal sections the scale bars correspond to 75 µm. (D) Two consecutive sections of TA muscle 
from 70 wo McA mice stained for IIx/IIb fibers and fibronectin shows the presence of fibrosis in muscle regions 
enriched in IIx fibers and its absence in IIx/IIb enriched sections. In (A–D) DAPI was used to stain cell nuclei.
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No progressive accumulation of glycogen in McArdle mice. We observed that glycogen levels were 
highly increased at all ages and muscles of McA mice compared with WT or HTZ using PAS stain (Fig. 8A). 
Biochemical quantification of glycogen in TA, quadriceps and gastrocnemius muscles in 8 and 70-week-old mice 
demonstrated that muscle glycogen levels were significantly higher in McA mice compared to WT (Fig. 8B). 
However, no difference in glycogen levels were found between 8 and 70-week-old McA mice in any of the three 
muscles examined (Fig. 8B). We analyzed the glycogen synthase (GS) expression and activation levels, as well as 
the expression levels of the of the different glycogen phosphorylase isoforms in gastrocnemius and TA muscles to 
Figure 4. Quantification of centrally nucleated fibers (CNF) among the different muscles and ages. (A) 
Percentage of CNF from the total amount of fibers. White columns correspond to wild-type (WT) mice whereas 
black columns correspond to McArdle (McA) mice. Only WT values from 8 wo mice are shown, as values WT 
values are similar among the three different ages. Each column represents the percentage of CNF resulting from 
the mean value obtained from 3 to 8 mice. The total number of mice used (N) is indicated at the bottom of each 
column. In each column between 491 (minimum) and 5,079 (maximum) fibers were counted (median 1682 
fibers). Error bars correspond to standard deviation (SD). (B) Percentage of CNF in the different muscles of 8 
and 70-week-old McA mice. For each age, muscles are represented together. Error bars correspond to SD. The 
non-parametric Kruskal-Wallis One-Way ANOVA with multiple comparisons test (Dunn’s test) was used for 
statistical analyses. Symbols: *p < 0.05.
Figure 5. Quantification of central nucleated fibers (CNF) in soleus, EDL and TA fiber types. (A) Percentage of 
CNF in soleus type I and IIa fibers. In each column between 223 (minimum) and 980 (maximum) fibers were 
counted (median 612 fibers). (B) Percentage of CNF in EDL type IIa, IIx and IIx/IIb fibers. In each column 
between 177 (minimum) and 651 (maximum) fibers were counted (median 413 fibers). (C) Percentage of 
CNF in TA type IIa, IIx and IIx/IIb fibers. In each column between 50 (minimum) and 930 (maximum) fibers 
were counted (median 520 fibers). The N at the bottom of each column represents the number of mice used to 
calculate the mean values. Error bars correspond to SD. The non-parametric Kruskal-Wallis One-Way ANOVA 
with multiple comparisons test (Dunn’s test) was used for statistical analyses. Symbols: *p < 0.05.
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Figure 6. Co-localization of embryonic myosin heavy chain (MHCe) with IIa and IIx fibers. (A) Two 
consecutive soleus sections from 8-week-old McArdle (McA) mice were stained for Collagen IV and MHCe in 
the first section, and MHC I and IIa in the second section. All detected MHCe positive fibers co-localized with 
MHC IIa staining. (B) Three consecutive soleus sections from 35-week-old McA mice were double stained for 
collagen IV/MHCe, MHCI/IIa and MHCIIa/IIx showing a colocalization of the MHCe and IIa stainings. (C) 
Two consecutive TA sections were double stained for Collagen IV and MHCe in the first section and MHCIIx 
and IIb in the second section, showing co-localization of the MHCe and MHCIIx stains. In all cases yellow 
asterisks mark identical fibers among sections and scale bars correspond to 150 µm. (D) Percentage of MHCe 
positive fibers in soleus, tibialis anterior (TA) and quadriceps of 8 and 70-week-old McA mice. N is the number 
of mice used to calculate the mean values. In each column between 619 (minimum) and 2250 (maximum) fibers 
were counted (median 1462 fibers). Error bars correspond to standard deviation (SD). The non-parametric 
Kruskal-Wallis One-Way ANOVA with multiple comparisons test (Dunn’s test) was used for statistical analyses.
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determine if any changes were responsible for the absence of progressive glycogen accumulation. Using quantita-
tive PCR, no significant change in Pygm, Pygb and Pygl mRNA levels were detected in gastrocnemius between 8 
and 70-week-old McA mice (Fig. 9A). Additionally, there was a complete absence of GP-M protein in gastrocne-
mius and TA from McA mice in the three ages analyzed (Fig. 9B). A significant increase in the phosphorylation 
(and thus inactivation) of GS in McA animals compared with WT in both gastrocnemius and TA was observed 
(Fig. 9B). Thus, to further assess whether the absence of progressive glycogen accumulation could be associated 
with an increase in lysosomal glycogen degradation we compared acid-alpha glucosidase (GAA) protein levels 
between 70-week-old WT and McA mice, and no changes in GAA protein levels were found (Fig. 9C).
Discussion
Since the publication in 2012 of the article describing the development and characterization of the McArdle 
mouse model6, several studies analyzing the biological consequences of GP-M deficiency in this model have 
been reported7–12. None of these studies accounted for the potential effects of aging on disease progression and 
its molecular consequences. Therefore, in the present study, we have performed a longitudinal characterization 
of the McArdle mouse model and have analyzed its survival rate. The most important observations that we have 
obtained are: (i) McA mice present high perinatal and post-weaning mortality; (ii) there is a lack of glycogen 
content increase in McA mice during aging (iii) there is a progressive muscle degeneration, fibrosis and inflam-
mation; (iv) soleus (oxidative) and quadriceps (glycolytic) are histologically less affected by disease progression 
than gastrocnemius, EDL and TA (glycolytic muscles); (v) there is a progressive degeneration of IIa, IIa/IIx and IIx 
fibers, whereas IIx/IIb and specially type I fibers are minimally affected and (vi) no major change in muscle fiber 
type composition occurs in McA mice during aging.
In this longitudinal study (from 2013 to 2018), we have collected sufficient data (from 139 matings and more 
than 2,000 offspring mice) to establish that difficulties associated with the management of the McA mouse colony 
are evident. The difficulties are caused by perinatal and post-weaning mortality of McA mice. Only two cases of 
fatal infantile form of McArdle disease (16 days and 13 weeks after birth, respectively)19,20 associated with hypo-
tonia19, respiratory deficiency19,20 and generalized weakness20 have been reported. In this context, we could not 
identify the causes for the perinatal death in McA mice and whether these were similar to those involved in the 
aforementioned fatal infantile forms in patients. However, it is possible that this issue is solvable by splitting litters 
and adding a lactating female mouse without litters. This may reduce the risk of fighting among littermates for 
food, which McA mice likely are not well equipped for due to their weaker condition.
Figure 7. Fiber size determination using the minimum Feret diameter (mFd). (A) Fiber size increase in soleus 
and quadriceps between 8 and 70-week-old McA mice. (B) Fiber size decrease in gastrocnemius, EDL and TA 
between 8 and 70-week-old McA mice. (C) Type I, IIa and IIx soleus fiber size from 8-week-old McA mice.  
(C) Type I soleus fiber size increase and IIa and IIx fiber size decrease between 8 and 70-week-old McA mice. 
Data is represented as a Scatter Plot. Each dot represents the mFd of a single fiber. A grey dot-line indicates the 
mean value of McA 8-week-old mice in each muscle. For each plot the mean value and the SD are also indicated 
in red. Below each plot is indicated the total amount of fibers (between brackets) counted. Between 3 to 5 mice 
were used in each column. One-Way ANOVA with post-hoc Tukey Honestly Significant Difference (HSD) test 
was used for statistical analyses. Symbols: *p < 0.05.
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We have observed an aging-associated progressive degeneration of muscle fibers, fibrosis and infiltration of 
inflammatory cells in all the studied muscles. However, this study has demonstrated a differential affection and 
progression of muscle with age. Quadriceps and soleus seemed to be less histologically affected by disease pro-
gression than gastrocnemius, EDL and TA. In the case of the soleus this observation was supported by an increase 
in fiber size and CNF with aging, suggesting that its muscle fibers might be able to withstand repeated cycles of 
damage and regeneration (this increase was not observed in gastrocnemius, EDL, TA and quadriceps muscle fibers 
indicating that these might not be as resistant to progressive damage, leading to their subsequent degeneration); 
and also by the presence of type I fiber, predominant in the soleus, that were almost structurally unaffected in 
McA mice at all ages analyzed. With respect to quadriceps, low fibrosis accumulation and mild fiber size increase 
during aging suggested that this muscle was less affected by disease progression than gastrocnemius, EDL and TA. 
Furthermore, we had previously reported a seven-fold lower expression of Pygm mRNA and GP-M protein in 
quadriceps in comparison to TA10. The lower glycogen levels in the quadriceps compared to TA muscle of McA 
mice, points to a moderate use of glycogen metabolism in quadriceps in comparison to other glycolytic muscles. 
The higher content of IIb fibers in quadriceps compared to TA and EDL confers an compensatory increase in 
uptake of glucose for direct glycolysis11,21–23; additionally, in rat fiber types it was observed that insulin-directed 
Figure 8. Histological and biochemical determination of glycogen in different muscles and ages of McArdle 
(McA) mice. (A) PAS staining of soleus, gastrocnemius, extensor digitorum longus (EDL), tibialis anterior (TA) 
and quadriceps in 8-week-old wild-type (WT) and heterozygous (HTZ) mice as well as in 8, 35 and 70-week-old 
McA mice. All the scale bars correspond to 150 µm. PAS staining was markedly increase in all sections from 
McA mice. (B) Biochemical determination of glycogen in TA, quadriceps and gastrocnemius of 8 and 70 wo WT 
and McA mice. N indicates the number of muscles used to calculate the mean values. Error bars correspond to 
SD. The non-parametric Kruskal-Wallis One-Way ANOVA with multiple comparisons test (Dunn’s test) was 
used for statistical analyses. Symbols: *p < 0.05.
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glucose uptake took place preferentially in IIa fibers (IIa > IIx, IIb), while in IIb fibers glucose uptake was mainly 
contraction-induced through AMPK mechanisms24. Thus, the contraction-induced glucose uptake for direct 
metabolism rather than glycogen synthesis might spare the quadriceps from devastating glycogen accumulation10. 
All these observations clearly indicated that the differential progression of muscle degeneration among glycolytic 
muscles in McA mice related to their different fiber type composition. In this regard, we previously reported 
that types I/IIa, IIa, IIa/IIx and IIx muscle fibers presented evident signs of degeneration in McA mice, while 
type IIx/IIb and specially type I fibers were almost unaffected10. In the present study, we have further confirmed 
these results as type I fibers had an almost normal morphology across all ages in McA mice, whereas there was 
a progressive degeneration of IIa, IIx and IIa/IIx fibers (i.e., from 8 to 70 weeks of age). Additionally, all actively 
regenerating fibers (i.e., MHCe positive) co-stained with IIa, IIx or IIa/IIx fiber type. The reason why type I/IIa, 
IIa, IIa/IIx and IIx fibers are more affected than type I and IIx/IIb hybrid fibers in the McArdle mouse model is 
unknown. Yet, a recent study on the proteomics of healthy murine single fiber types25 showed a distinct proteomic 
content among fiber types that might help to explain the observed differences in fiber type resistance to degen-
eration. In this regard, Mitsugurmin-53/Trim 72, a protein that plays a role in membrane repair, was found to 
be considerably more abundant in type I than in all another fiber types25. Additionally, we previously showed in 
McA mice that type I fibers presented lower levels of glycogen than type II fibers6, and the glycogen content levels 
in the soleus of these mice were lower than in the glycolytic muscles gastrocnemius and EDL7, suggesting a direct 
correlation between muscle fiber glycogen content and damage. Selective type II fiber degeneration has been 
previously reported in other myopathies such as Duchenne muscular dystrophy, facioscapulohumeral muscular 
dystrophy, myotonic dystrophy type 226 as well as in the alpha-glucosidase knock-out mouse model that mimics 
the late-onset form of Pompe disease27,28. Several reports also indicate that age-related decline in muscle mass 
is fiber type-specific, principally affecting type II fibers, with type I fibers remaining largely unaffected25,29–31. 
Although no major change in fiber type composition was observed in McA mice during the aging process, we 
observed a trend towards an increase in glycolytic metabolism in the soleus muscle with aging in McA mice, 
Figure 9. Expression studies of genes involved in glycogen synthesis and degradation. (A) Quantitative PCR 
analysis of the different glycogen phosphorylase isoforms in the gastrocnemius muscle. In the Pygb and Pygl 
studies, the relative Pygm expression values in one gastrocnemius muscle is shown. (B) Western blot analysis of 
GPM, total GS (GST) and phospho serine 641 GS (pGSSer 641) in gastrocnemius and tibialis anterior (TA) muscles. 
Glyceraldehyde-3-Phosphate Dehydrogenase (Gapdh) was used as a loading control. The blot images were 
obtained with Fujifilm LAS 3000 imager. These are cropped images. Uncropped original images can be found in 
Supplementary Fig. 5. The relative quantification for GPM protein results from GPM/Gapdh ratio after image J 
quantification as well as the relative quantification of the phosphorylated fraction of (inactive) GS protein. This 
quantification results from pGS/GST ratio after image J quantification. (C) Alpha acid glucosidase protein levels 
in 70 wo WT and McA mice determined by western blot. Ponceau staining was used for loading normalization. 
Error bars correspond to standard deviation (SD). The non-parametric Kruskal-Wallis One-Way ANOVA with 
multiple comparisons test (Dunn’s test) was used for statistical analyses. Symbols: *p < 0.05.
13Scientific RepoRts |          (2019) 9:5116  | https://doi.org/10.1038/s41598-019-41414-8
www.nature.com/scientificreportswww.nature.com/scientificreports/
as indicated by a decrease in the percentage of oxidative fibers paralleled by an increase in the proportion of 
glycolytic fibers in 70-week-old animals. Although the physiologic significance of this observation still needs to 
be elucidated, it might imply the necessity of this muscle to diversify its metabolism as a protective mechanism 
against the cytosolic glycogen degradation blockade. Finally, we have shown that progressive muscle degenera-
tion in McA mice during aging is not accompanied by an increase in their muscle glycogen content. This absence 
of progressive glycogen accumulation was not associated with a re-expression of the Pygb and/or Pygl genes in 
mature muscle. Additionally, a significant increase in GS phosphorylation was observed in McA mouse muscles 
in the three ages analyzed indicating that GS inactivation plays an important role to explain the absence of glyco-
gen content increase. However, some degree of glycogen phosphorylase-independent glycogen degradation can-
not be discarded as it remains to be determined whether autophagy-related pathways are progressively involved 
through aging in McA disease. Although no significant increase in lysosomal GAA was observed in older mice, 
the enzyme activity might be sufficient to handle potential deviation of glycogen degradation to the lysosomal 
pathway. Future studies should elucidate whether lysosomal glycogen degradation is affected in McA mice and 
might determine the link between cytosolic and lysosomal glycogen metabolism in McA disease, as well as its 
potential therapeutic implications in patients. On the other hand, our finding of an aging-associated progressive 
degeneration of muscle fibers, fibrosis and infiltration of inflammatory cells in all the studied McA mouse muscles 
(although with varying degrees of affectation depending on muscle type) is important from a translational point 
of view. Indeed, we have reported in the Spanish Registry of McA patients [originally n = 2394 and n = 333 in the 
more recent update5] that age has a detrimental effect on several phenotypic features of the disease, especially 
on muscle fixed weakness, which affects mostly proximal/trunk muscles4. The mean age (57 ± 19 years) of those 
patients in the highest severity class 3 (that includes presence of fixed muscle weakness) is indeed higher than in 
those in the lower severity classes 1 (46 ± 19 years, p = 0.007)5. Thus, the finding of age-associated muscle fibrosis 
and infiltration found here might provide mechanistic insight for the reported findings in the older patients and 
should be kept in mind as an additional hallmark of the disease.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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